Company / Capital Returned to Shareholders per Share
GYRE THERAPEUTICS, INC. Capital Returned to Shareholders per Share History
FY2022-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.59
FY2022
5-year range
$0.59 / $0.59
FY2022-FY2022
Trend
-
vs FY2021
Sector context
#29 of 51
Health Care
What the data says
At $0.59, GYRE THERAPEUTICS, INC.'s capital returned to shareholders per share ranks #29 of 51 in the Health Care sector.
Based on SEC 10-K filings.
0.59 in FY2022.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#29 of 51 in Health CareTop 57% of 51This company $0.59 Sector average $2.74
▼
-78.2% below sector average
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.59 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026